Speed to market
Compressed timelines and flexible designs
When it comes to launching clinical or commercial manufacturing operations for advanced-therapy medicinal products (ATMPs), we recognise the need for compressed timelines and flexible designs to enhance speed-to-market. We also offer expertise in project phasing to accommodate low CAPEX spend and incremental investment.
Expertise in cell & gene therapy design:
- Site master planning
- Next generation manufacturing
- Buffer/media management
- Biocontainment
- Equipment layouts & program of spaces
- Constructability
- CQV master planning
- Process technology assessments
- Process closure risk assessments
- Single-use design
- Utility capacity assessments
- Manufacturing capacity and production time modelling
Master planning
During master planning, our experts optimise the flow of personnel, materials, and products throughout a facility (and site when applicable) by utilising ballroom designs and single-use technologies to allow for future scaling and reconfiguration.
Next generation manufacturing
With next generation manufacturing, our subject matter experts collaborate on concepts for process intensification and digitalisation to bring future ready solutions to market. We understand the importance of minimising site interruptions and downtime to existing processing areas as improvements are implemented.
